Trials / Completed
CompletedNCT06968117
Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Centre Hospitalier de Gonesse · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.
Conditions
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2025-05-13
- Last updated
- 2025-05-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06968117. Inclusion in this directory is not an endorsement.